Daily as of 3 Nov 16:00 ET
- Price
- above both $10.35 vs 50 $9.37 / 200 $7.53
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Jul 2026 · projected 28 bars out
XERS | Xeris Biopharma HoldingsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$10.35
+$0.18 (+1.77%)
Xeris Biopharma Holdings (XERS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $10.71 vs 50 $7.43 / 200 $4.34
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 11 Nov 2024 · projected 17 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $10.35 vs 50 $10.30 / 200 $8.75
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 15 Jun 2026 · projected 18 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Jul 2026 | 🟨Golden steep | daily | 28 bars out | Not tested |
| 15 Jun 2026 | 🟨Golden | 4-hour | 18 bars out | Not tested |
| 17 Mar 2026 | 💀Death moderate | daily | 26 bars out | Not tested |
| 8 Dec 2025 | 💀Death | 4-hour | 30 bars out | 3 bar cross test |
| week of 11 Nov 2024 | 🟨Golden moderate | weekly | 17 bars out | Not tested |
About XERS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$16.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall